Man Group plc bought a new stake in OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 150,854 shares of the medical instruments supplier’s stock, valued at approximately $673,000. Man Group plc owned approximately 0.22% of OraSure Technologies as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also recently bought and sold shares of OSUR. Legal & General Group Plc bought a new position in shares of OraSure Technologies during the 2nd quarter worth approximately $30,000. Prudential Financial Inc. acquired a new position in OraSure Technologies during the second quarter worth $31,000. Quadrature Capital Ltd acquired a new position in OraSure Technologies during the fourth quarter worth $28,000. Diversify Advisory Services LLC bought a new position in OraSure Technologies in the second quarter valued at $47,000. Finally, Diversify Wealth Management LLC bought a new position in OraSure Technologies in the first quarter valued at $36,000. Institutional investors and hedge funds own 93.50% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have commented on OSUR. Weiss Ratings reissued a “sell (d-)” rating on shares of OraSure Technologies in a research report on Tuesday. Wall Street Zen upgraded OraSure Technologies from a “sell” rating to a “hold” rating in a report on Monday, August 10th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, OraSure Technologies currently has an average rating of “Reduce” and an average price target of $3.00.
OraSure Technologies Stock Down 0.8%
Shares of NASDAQ OSUR opened at $3.58 on Friday. The business’s 50 day moving average price is $4.00 and its two-hundred day moving average price is $3.56. The company has a market cap of $246.91 million, a PE ratio of -5.19 and a beta of 0.99. OraSure Technologies, Inc. has a twelve month low of $2.08 and a twelve month high of $4.58.
OraSure Technologies Profile
OraSure Technologies, Inc is a Bethlehem, Pennsylvania–based diagnostic and medical device company specializing in the development, manufacture and commercialization of point-of-care and self-testing products. Founded in 1988, OraSure has built a portfolio of oral fluid and other non-invasive specimen collection technologies that support the detection of infectious diseases, drugs of abuse, and health and wellness biomarkers.
The company’s flagship product, the OraQuick® rapid HIV test, was the first Food and Drug Administration–approved over-the-counter oral fluid test for the detection of HIV-1/2 antibodies.
See Also
- Five stocks we like better than OraSure Technologies
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR – Free Report).
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
